Furthermore, high-risk patients have increased proportions of CD8+ T cells, activated NK cells, and regulatory T cells, all of which suppress antitumour immunity and contribute to immune dysfunction and tumour progression [30]. This evidence concerns the gene CD8A and neoplasm.